HK1168101A1 - Process for manufacturing 2-[(3,5-difluoro-3'-methoxy-1,1'-biphenyl-4- yl)amino]nicotinic acid - Google Patents
Process for manufacturing 2-[(3,5-difluoro-3'-methoxy-1,1'-biphenyl-4- yl)amino]nicotinic acidInfo
- Publication number
- HK1168101A1 HK1168101A1 HK12108881.1A HK12108881A HK1168101A1 HK 1168101 A1 HK1168101 A1 HK 1168101A1 HK 12108881 A HK12108881 A HK 12108881A HK 1168101 A1 HK1168101 A1 HK 1168101A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- difluoro
- biphenyl
- methoxy
- amino
- manufacturing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/78—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
- C07C217/80—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/803—Processes of preparation
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pyridine Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09382212A EP2314577A1 (en) | 2009-10-16 | 2009-10-16 | Process for manufacturing 2-[(3,5-difluoro-3'-methoxy-1,1'-biphenyl-4-yl)amino]nicotinic acid |
| PCT/EP2010/006283 WO2011045059A1 (en) | 2009-10-16 | 2010-10-14 | Process for manufacturing 2-[(3,5-difluoro-3'-methoxy-1,1'-biphenyl-4-yl)amino]nicotinic acid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1168101A1 true HK1168101A1 (en) | 2012-12-21 |
Family
ID=41402565
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK12108881.1A HK1168101A1 (en) | 2009-10-16 | 2012-09-12 | Process for manufacturing 2-[(3,5-difluoro-3'-methoxy-1,1'-biphenyl-4- yl)amino]nicotinic acid |
Country Status (32)
| Country | Link |
|---|---|
| US (1) | US8598363B2 (es) |
| EP (2) | EP2314577A1 (es) |
| JP (1) | JP5809630B2 (es) |
| KR (1) | KR101699999B1 (es) |
| CN (2) | CN102574800B (es) |
| AU (1) | AU2010306098B2 (es) |
| BR (1) | BR112012008464B1 (es) |
| CA (1) | CA2776328C (es) |
| CL (1) | CL2012000739A1 (es) |
| CO (1) | CO6430508A2 (es) |
| CR (1) | CR20120185A (es) |
| CY (1) | CY1115161T1 (es) |
| DK (1) | DK2488497T3 (es) |
| EA (1) | EA022805B1 (es) |
| ES (1) | ES2467165T3 (es) |
| HK (1) | HK1168101A1 (es) |
| HR (1) | HRP20140523T1 (es) |
| IL (1) | IL218446A (es) |
| IN (1) | IN2012DN01938A (es) |
| ME (1) | ME01812B (es) |
| MX (1) | MX2012004033A (es) |
| MY (1) | MY160308A (es) |
| NZ (1) | NZ598429A (es) |
| PE (1) | PE20121173A1 (es) |
| PL (1) | PL2488497T3 (es) |
| PT (1) | PT2488497E (es) |
| RS (1) | RS53319B (es) |
| SI (1) | SI2488497T1 (es) |
| SM (1) | SMT201400064B (es) |
| UA (1) | UA107811C2 (es) |
| WO (1) | WO2011045059A1 (es) |
| ZA (1) | ZA201201563B (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2319596B1 (es) | 2006-12-22 | 2010-02-08 | Laboratorios Almirall S.A. | Nuevos derivados de los acidos amino-nicotinico y amino-isonicotinico. |
| UY31272A1 (es) * | 2007-08-10 | 2009-01-30 | Almirall Lab | Nuevos derivados de ácido azabifenilaminobenzoico |
| EP2135610A1 (en) * | 2008-06-20 | 2009-12-23 | Laboratorios Almirall, S.A. | Combination comprising DHODH inhibitors and methotrexate |
| EP2239256A1 (en) | 2009-03-13 | 2010-10-13 | Almirall, S.A. | Sodium salt of 5-cyclopropyl-2-{[2-(2,6-difluorophenyl)pyrimidin-5-yl]amino}benzoic acid as DHODH inhibitor |
| JP7343373B2 (ja) * | 2019-12-02 | 2023-09-12 | 花王株式会社 | 香料組成物 |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT837710E (pt) | 1995-06-21 | 2002-05-31 | Sofotec Gmbh & Co Kg | Cartucho de po farmaceutico com dispositivo de doseamento integrado e inalador para medicamentos em po |
| DE19547648A1 (de) | 1995-12-20 | 1997-06-26 | Hoechst Ag | Zubereitung, enthaltend High Density Lipoproteine und Crotonsäureamidderivate |
| DE19610955A1 (de) | 1996-03-20 | 1997-09-25 | Hoechst Ag | Kombinationspräparat, enthaltend 5-Methylisoxazol-4-carbonsäure-(4-trifluormethyl)- anilid und N-(4-Trifluormethylphenyl)-2-cyan-3- hydroxycrotonsäureamid |
| GB9804343D0 (en) | 1998-02-27 | 1998-04-22 | Univ Cardiff | Chemical compounds |
| BR0011728A (pt) | 1999-06-10 | 2002-02-26 | Warner Lambert Co | Método de inibir a agregação de proteìna amilóide e imagem de depósitos de amilóide |
| SI1381356T1 (sl) | 2001-04-05 | 2008-12-31 | Aventis Pharma Inc | Uporaba (Z)-2-ciano-3-hidroksi-but-2-enojska kislina-(4'-trifluorometilfenil)-amida za zdravljenje multiple skleroze |
| PE20030120A1 (es) | 2001-06-19 | 2003-02-12 | Merck & Co Inc | Sal amina de un antagonista de receptor de integrin |
| DE10129703A1 (de) | 2001-06-22 | 2003-01-02 | Sofotec Gmbh & Co Kg | Zerstäubungssystem für eine Pulvermischung und Verfahren für Trockenpulverinhalatoren |
| MXPA04000224A (es) | 2001-07-10 | 2005-07-25 | 4Sc Ag | Novedosos compuestos como agentes antiinflamatorios, inmunomoduladores y antiproliferativos. |
| US7258118B2 (en) | 2002-01-24 | 2007-08-21 | Sofotec Gmbh & Co, Kg | Pharmaceutical powder cartridge, and inhaler equipped with same |
| DE10202940A1 (de) | 2002-01-24 | 2003-07-31 | Sofotec Gmbh & Co Kg | Patrone für einen Pulverinhalator |
| JP2005526724A (ja) * | 2002-02-13 | 2005-09-08 | グラクソ グループ リミテッド | 抗精神病剤としてのベンゼンスルホンアミド誘導体 |
| EP1499592A4 (en) * | 2002-04-13 | 2010-01-13 | Hanlim Pharmaceutical Co Ltd | AMLODIPINE NICOTINATE AND PROCESS FOR PREPARING THE SAME |
| AR042206A1 (es) * | 2002-11-26 | 2005-06-15 | Novartis Ag | Acidos fenilaceticos y derivados |
| WO2004056746A1 (en) | 2002-12-23 | 2004-07-08 | 4Sc Ag | Cycloalkene dicarboxylic acid compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| WO2004056747A1 (en) | 2002-12-23 | 2004-07-08 | 4Sc Ag | Dhodh-inhibitors and method for their identification |
| SE0400234D0 (sv) | 2004-02-06 | 2004-02-06 | Active Biotech Ab | New compounds, methods for their preparation and use thereof |
| JP2008500393A (ja) | 2004-05-21 | 2008-01-10 | ザ ユーエービー リサーチ ファンデーション | ピリミジン合成インヒビターに関する組成物および方法 |
| WO2006022442A1 (ja) | 2004-08-24 | 2006-03-02 | Santen Pharmaceutical Co., Ltd. | ジヒドロオロテートデヒドロゲナーゼ阻害活性を有する新規複素環アミド誘導体 |
| EP1804782A1 (en) | 2004-10-19 | 2007-07-11 | Aventis Pharmaceuticals Inc. | Use of (z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide for treating inflammatory bowel disease |
| ES2265276B1 (es) | 2005-05-20 | 2008-02-01 | Laboratorios Almirall S.A. | Derivados de 4-(2-amino-1-hidroxietil)fenol como agonistas del receptor beta2 adrenergico. |
| CN1696100B (zh) * | 2005-06-01 | 2010-11-24 | 黑龙江福和华星制药集团股份有限公司 | 痤疮治疗药阿达帕林的新型简捷合成方法 |
| ES2319596B1 (es) * | 2006-12-22 | 2010-02-08 | Laboratorios Almirall S.A. | Nuevos derivados de los acidos amino-nicotinico y amino-isonicotinico. |
| ES2366000T3 (es) | 2007-02-06 | 2011-10-14 | Chelsea Therapeutics, Inc. | Nuevos compuestos, métodos para su preparación y uso de los mismos. |
| UY31272A1 (es) | 2007-08-10 | 2009-01-30 | Almirall Lab | Nuevos derivados de ácido azabifenilaminobenzoico |
| EP2135610A1 (en) | 2008-06-20 | 2009-12-23 | Laboratorios Almirall, S.A. | Combination comprising DHODH inhibitors and methotrexate |
| EP2210615A1 (en) | 2009-01-21 | 2010-07-28 | Almirall, S.A. | Combinations comprising methotrexate and DHODH inhibitors |
| EP2230232A1 (en) | 2009-03-13 | 2010-09-22 | Almirall, S.A. | Addition salts of tromethamine with azabiphenylaminobenzoic acid derivatives as DHODH inhibitors |
| EP2239256A1 (en) | 2009-03-13 | 2010-10-13 | Almirall, S.A. | Sodium salt of 5-cyclopropyl-2-{[2-(2,6-difluorophenyl)pyrimidin-5-yl]amino}benzoic acid as DHODH inhibitor |
| EP2228367A1 (en) | 2009-03-13 | 2010-09-15 | Almirall, S.A. | Addition salts of amines containing hydroxyl and/or carboxylic groups with amino nicotinic acid derivatives as DHODH inhibitors |
-
2009
- 2009-10-16 EP EP09382212A patent/EP2314577A1/en not_active Withdrawn
-
2010
- 2010-10-14 NZ NZ598429A patent/NZ598429A/en unknown
- 2010-10-14 ME MEP-2014-50A patent/ME01812B/me unknown
- 2010-10-14 PL PL10765586T patent/PL2488497T3/pl unknown
- 2010-10-14 BR BR112012008464-0A patent/BR112012008464B1/pt active IP Right Grant
- 2010-10-14 AU AU2010306098A patent/AU2010306098B2/en active Active
- 2010-10-14 EA EA201200594A patent/EA022805B1/ru unknown
- 2010-10-14 PT PT107655862T patent/PT2488497E/pt unknown
- 2010-10-14 CA CA2776328A patent/CA2776328C/en active Active
- 2010-10-14 JP JP2012533527A patent/JP5809630B2/ja active Active
- 2010-10-14 DK DK10765586.2T patent/DK2488497T3/da active
- 2010-10-14 MY MYPI2012001685A patent/MY160308A/en unknown
- 2010-10-14 CN CN201080046816.8A patent/CN102574800B/zh active Active
- 2010-10-14 MX MX2012004033A patent/MX2012004033A/es active IP Right Grant
- 2010-10-14 KR KR1020127009609A patent/KR101699999B1/ko active IP Right Grant
- 2010-10-14 SI SI201030632T patent/SI2488497T1/sl unknown
- 2010-10-14 RS RS20140253A patent/RS53319B/en unknown
- 2010-10-14 PE PE2012000491A patent/PE20121173A1/es active IP Right Grant
- 2010-10-14 US US13/501,847 patent/US8598363B2/en active Active
- 2010-10-14 ES ES10765586.2T patent/ES2467165T3/es active Active
- 2010-10-14 EP EP10765586.2A patent/EP2488497B1/en active Active
- 2010-10-14 WO PCT/EP2010/006283 patent/WO2011045059A1/en active Application Filing
- 2010-10-14 UA UAA201205649A patent/UA107811C2/ru unknown
- 2010-10-14 CN CN201410085756.0A patent/CN103936668A/zh active Pending
-
2012
- 2012-03-01 ZA ZA2012/01563A patent/ZA201201563B/en unknown
- 2012-03-01 IL IL218446A patent/IL218446A/en active IP Right Grant
- 2012-03-05 IN IN1938DEN2012 patent/IN2012DN01938A/en unknown
- 2012-03-23 CL CL2012000739A patent/CL2012000739A1/es unknown
- 2012-04-16 CR CR20120185A patent/CR20120185A/es unknown
- 2012-04-16 CO CO12061780A patent/CO6430508A2/es active IP Right Grant
- 2012-09-12 HK HK12108881.1A patent/HK1168101A1/xx unknown
-
2014
- 2014-06-03 SM SM201400064T patent/SMT201400064B/xx unknown
- 2014-06-05 HR HRP20140523AT patent/HRP20140523T1/hr unknown
- 2014-06-06 CY CY20141100405T patent/CY1115161T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL244812B (en) | Process for preparing 23(s)-methyl-12α,7α,3α-trihydroxy-6α-ethyl-5β-cholan-24-butyric acid | |
| HK1139122A1 (zh) | 用於製備 -聯苯基- -氨基- -甲基戊酸的方法 | |
| EP2519101A4 (en) | AMINO ACID CONJUGATES OF QUÉTIAPINE, PROCESS FOR THE PRODUCTION AND USE THEREOF | |
| EP2175029A4 (en) | LACTIC PRODUCTION PROCESS | |
| EP2360263A4 (en) | PROCESS FOR THE PREPARATION OF L-AMINO ACID | |
| PL2137206T3 (pl) | Sposób wytwarzania kwasu tauroursodeoksycholowego | |
| EP2302066A4 (en) | METHOD FOR PRODUCING AMINOHYDROXYBENZOIC ACID | |
| HK1177211A1 (en) | Method for preparing tetrazole methanesulfonic acid salts, and novel compound used in same | |
| HK1168101A1 (en) | Process for manufacturing 2-[(3,5-difluoro-3'-methoxy-1,1'-biphenyl-4- yl)amino]nicotinic acid | |
| EP2289875A4 (en) | PROCESS FOR PRODUCING PERFLUOROALCANESULFINIC ACID SALT | |
| HK1150163A1 (en) | Method for preparing trifluoromethanesulphinic acid | |
| EP2361247A4 (en) | FLUPIRTINHYDROCHLORID-maleic acid co-crystal | |
| EP2415869A4 (en) | MODIFIED OLIGO-NUCLEIC ACID MOLECULE, PROCESS FOR PREPARATION AND USES THEREOF | |
| IL210278A0 (en) | Method for producing 3 - methyl - 2 - thiophenecarboxylic acid | |
| SG10201400650QA (en) | Method For Producing L-Amino Acid | |
| PL2187863T3 (pl) | Przeciwpotowe sole okso-heksameryczny cyrkon-oktaaminokwasu | |
| EP2330212A4 (en) | NEW CERAMIDASTINE COMPOUND AND METHOD FOR THE PRODUCTION AND USE THEREOF | |
| EP2327789A4 (en) | NEW COMPOUND SIGNAMYCIN, METHOD FOR THE PRODUCTION THEREOF AND USE THEREOF | |
| PL393268A1 (pl) | Kwas 2-amino-6-dihydroksyborylo-1,2,3,4-tetrahydronaftaleno-2-karboksylowy i sposób jego wytwarzania | |
| EP2397545A4 (en) | PROCESS FOR PRODUCING AMINO ACID | |
| HK1151801A1 (en) | 15,16-methylene-17-hydroxy-19-nor-21-carboxylic acid | |
| EP2269979A4 (en) | DIAMINATED ACID DERIVATIVE MATERIAL, METHOD FOR PRODUCING THE SAME, AND PROCESS FOR PRODUCING DIAMINATED ACID DERIVATIVE | |
| EP2323976A4 (en) | ARYLALKYLCARBOXYLIC ACID SALTS, PROCESS FOR PREPARATION THEREOF AND GALENIC FORMS | |
| EP2327685A4 (en) | PROCESS FOR PRODUCTION OF ACID -AMINATED -TRIFLUOROMETHYL- -SUBSTITUTED | |
| EP2216410A4 (en) | PROCESS FOR PREPARING AMINO ACID |